reportingrisk.com← the monitorSEC reporting failures, scored and checked against what happened next

Or browse all companies A–Z.

Zivo Bioscience, Inc.

ZIVO · OTC

No reporting failures in the last 12 months

It filed on time and stood behind its numbers. Of companies scoring zero, 4.0% were delisted, went bankrupt, restated or stopped filing within the following year.

$16Mstalepublic float
2022-04-15most recent failure
2026-03-31delisted or deregistered
2022-04-15declared past accounts unreliable

Score over time

01234202220232024202520262022-01-01 · score 12021-12-09 auditor change2022-04-01 · score 32022-03-31 filed late (10-K) · accounts not ready2022-02-16 auditor change2021-12-09 auditor change2022-07-01 · score 42022-04-15 accounts unreliable2022-03-31 filed late (10-K) · accounts not ready2022-02-16 auditor change2021-12-09 auditor change2022-10-01 · score 42022-04-15 accounts unreliable2022-03-31 filed late (10-K) · accounts not ready2022-02-16 auditor change2021-12-09 auditor change2023-01-01 · score 32022-04-15 accounts unreliable2022-03-31 filed late (10-K) · accounts not ready2022-02-16 auditor change2023-04-01 · score 12022-04-15 accounts unreliable

Hover or tap a dot to see the filings behind that score.

Why they said they were late

Zivo Bioscience, Inc. (the “Company”) is unable to file its annual report on Form 10-K for the period ended December 31, 2021 (the “Annual Report”) with the Securities and Exchange Commission (the “SEC”) within the prescribed time period without unreasonable effort or expense. The Company requires additional time to complete its review because the Company has incurred more time and expense in preparing its annual financial statements and assessing the effectiveness of its internal controls over financial reporting and disclosure controls and procedures. The Company currently anticipates filing the Annual Report on or before the fifteenth calendar day extension provided by Rule 12b-25. 4

NT 10-K, filed 2022-03-31 · accounts not ready

What it filed

2022-04-15accounts declared unreliable SEC →

2022-03-31filed late (10-K)accounts not ready SEC →

Zivo Bioscience, Inc. (the “Company”) is unable to file its annual report on Form 10-K for the period ended December 31, 2021 (the “Annual Report”) with the Securities and Exchange Commission (the “SEC”) within the prescribed time period without unreasonable effort or expense. The Company requires additional time to complete its review because the Company has incurred more time and expense in preparing its annual financial statements and assessing the effectiveness of its internal controls over financial reporting and disclosure controls and procedures. The Company currently anticipates filing the Annual Report on or before the fifteenth calendar day extension provided by Rule 12b-25. 4

2022-02-16auditor changed or resigned SEC →

2021-12-09auditor changed or resigned SEC →

About this score

reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.

Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.

See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.

Every item above is a filing this company made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not investment advice

reportingrisk.com← back to the monitorAll companies A-Z · RSS · found an error? hello@reportingrisk.com